ABUS vs VMC
Arbutus Biopharma Corp (ABUS) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the ABUS and VMC stock pages for the full models.
Not investment advice.